Document Detail

Endoscopic management of vesicoureteral reflux: does it stand the test of time?
MedLine Citation:
PMID:  12477657     Owner:  NLM     Status:  MEDLINE    
Endoscopic subureteral injection of tissue-augmenting substances, a 15-minute outpatient procedure has become an alternative to long-term antibiotic prophylaxis and surgical intervention in the treatment of vesicoureteral reflux (VUR) in children. This paper reviews the long-term results of endoscopic treatment of reflux using various tissue-augmenting substances presently available. In terms of effectiveness and long-term successful results, polytetrafluoroethylene is still the most reliable injectable material for the endoscopic treatment of VUR.
Boris Chertin; Prem Puri
Related Documents :
21757967 - Prognosis and outcome of the tympanic membrane flap at traumatic tympanic membrane perf...
19092347 - Randomized controlled trial of laparoscopic heller myotomy plus dor fundoplication vers...
22032447 - A prospective study evaluating spontaneous healing of aetiology, size and type-differen...
15457297 - Endoscopic "antireflux" procedures: not yet ready for prime time.
8522997 - Heterotopic ossification following primary total knee arthroplasty.
18317087 - Meta-analysis of mandibular distraction osteogenesis: clinical applications and functio...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European urology     Volume:  42     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-12-12     Completed Date:  2003-07-25     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  598-606; discussion 606     Citation Subset:  IM    
Children's Research Centre, Our Lady's Hospital for Sick Children, University College Dublin, Dublin, Ireland
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biocompatible Materials
Chondrocytes / transplantation
Hyaluronic Acid
Injections / methods
Time Factors
Vesico-Ureteral Reflux / therapy*
Reg. No./Substance:
0/Biocompatible Materials; 0/Dimethylpolysiloxanes; 0/Silicones; 0/deflux; 0/glutaraldehyde-cross-linked collagen; 63148-62-9/baysilon; 9002-84-0/Polytetrafluoroethylene; 9004-54-0/Dextrans; 9004-61-9/Hyaluronic Acid; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of 100 laparoscopic varicocele operations with preservation of testicular artery and liga...
Next Document:  Blunt renal trauma: biomechanics and origination of renal lesions.